Silencing genes in the vaginal mucosa by topical application of a cholesterol‐modified siRNA to inhibit HIV transmission
Journal of the European Academy of Dermatology and Venereology · 2023
DOI: 10.1111/jdv.18877 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2023. Verfasst von Merilyn H Hibma. Beteiligte Einrichtung: Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Vagina, HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Zitieren
APA
Hibma, M. H. (2023). Silencing genes in the vaginal mucosa by topical application of a cholesterol‐modified siRNA to inhibit HIV transmission. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.18877
Vancouver
Hibma MH. Silencing genes in the vaginal mucosa by topical application of a cholesterol‐modified siRNA to inhibit HIV transmission. Journal of the European Academy of Dermatology and Venereology. 2023. doi:10.1111/jdv.18877
BibTeX
@article{Hibma2023,
author = {Hibma, Merilyn H},
title = {Silencing genes in the vaginal mucosa by topical application of a cholesterol‐modified siRNA to inhibit HIV transmission},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2023},
doi = {10.1111/jdv.18877}
}
EUVIMED